Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hematologic Malignancies
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

A molecular profile of a patient with hematologic malignancy, for whom standard-of-care had failed, is identified using next generation sequencing. Patients are assigned to early clinical trials of targeted agent based on the molecular profiling or physician's choice. The improvement of outcomes in the intention-to-treat population is investigated.

Provided treatments

  • Other: Matching on the basis of molecular analysis
  • Other: Matching on the basis of physician's choice
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02758080. The sponsor of the trial is Seoul National University Hospital and it is looking for 90 volunteers for the current phase.
Official trial title:
Pragmatic Clinical Trial of Matching Malignant Hematologic Cancer Patients With Adequate Early Phase Clinical Trials by Next-generation Sequencing